INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Invivo Therapeutics Holdings Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2010 to Q3 2023.
  • Invivo Therapeutics Holdings Corp. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2023 was 3.11M shares, a 123% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.54M shares, a 16.1% increase from 2021.
  • Invivo Therapeutics Holdings Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.32M shares, a 80.8% decline from 2020.
  • Invivo Therapeutics Holdings Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 6.9M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 3.11M +1.71M +123% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 3.11M +1.72M +125% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 2.74M +1.37M +99.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 1.54M +213K +16.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 1.39M +20.6K +1.51% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 1.38M +12.9K +0.94% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 1.37M +191K +16.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 1.32M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 1.37M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 1.37M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 1.18M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2016 28.2M +3.26M +13.1% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-06
Q3 2015 27M +3.65M +15.6% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-04
Q2 2015 26.5M +4.69M +21.5% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-05
Q1 2015 24.9M +6.37M +34.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 88.3M +14.3M +19.4% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-11
Q3 2014 23.4M -55.2M -70.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 21.8M -50.6M -69.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 18.5M -47.5M -71.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 74M +10.8M +17% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 78.6M +13.5M +20.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 72.4M +8.28M +12.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 66M +8.04M +13.9% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-09
Q4 2012 63.2M +11.3M +21.8% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-11
Q3 2012 65.1M +13.2M +25.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 64.1M +12.4M +24.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 58M +6.34M +12.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 51.9M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 51.9M +20.7M +66.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 51.7M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 51.7M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 31.1M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.